Robert Madelin is the Chairman and Chief Strategist at FIPRA International Ltd. Robert is a rare politician with hands-on experience guiding pan-European policy for IT and healthcare. From 2004-2016 he was the Director General for Communications Networks, Content and Technology (CONNECT) and Director General for Health and Consumer Policy (SANCO). Robert Madelin was also a negotiator for both EU and UK international trade and investment, and served in the Cabinet of European Commission Vice-President Leon Brittan. 

His 2016 book, “Opportunity Now: Europe's mission to innovate” outlines how the EU can better manage innovation, which is of particular interest given Europe’s immediate need to find solutions to solving the current lockdowns for Covid-19. In this podcast we discuss practical solutions for addressing Europe’s need for technical leadership, as well as how the EU can adapt to meet the structural challenges exposed by the response to the pandemic. We also discuss several ongoing regulatory reviews related to pharmaceutical incentives including those targeting orphan drugs and medicinal products.

Robert Madelin is the Chairman and Chief Strategist at FIPRA International Ltd. Robert is a rare politician with hands-on experience guiding pan-European policy for IT and healthcare. From 2004-2016 he was the Director General for Communications Networks, Content and Technology (CONNECT) and Director General for Health and Consumer Policy (SANCO). Robert Madelin was also a negotiator for both EU and UK international trade and investment, and served in the Cabinet of European Commission Vice-President Leon Brittan. <br> <br>His 2016 book, “Opportunity Now: Europe's mission to innovate” outlines how the EU can better manage innovation, which is of particular interest given Europe’s immediate need to find solutions to solving the current lockdowns for Covid-19. In this podcast we discuss practical solutions for addressing Europe’s need for technical leadership, as well as how the EU can adapt to meet the structural challenges exposed by the response to the pandemic. We also discuss several ongoing regulatory reviews related to pharmaceutical incentives including those targeting orphan drugs and medicinal products.

Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.

<p>Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast.  Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.</p>

Duane Schulthess, Managing Director of Vital Tran…

Vital Health Podcast

Robert Madelin is the Chairman and Chief Strategi…